1-800-OVARIAN (1-800-682-7426)
bclose

Affiliates & Partners

Research teams at Roswell Park Cancer Institute (where the registry is housed) and across the globe use the data collected by the Familial OCR to seek better methods for detecting, treating, curing and eventually preventing familial ovarian cancer.

The registry is grateful to work with the following medical and research organizations in its continued mission to ensure the world’s top research teams can continue their progress seeking better methods for detecting, treating, curing and eventually preventing familial ovarian cancer.

Ovarian Cancer Association Consortium (OCAC)
OCAC is a forum of investigators of case-control studies of ovarian cancer, formed in April 2005. Many groups are conducting studies with the aim of identifying genes that may be related to the risk of ovarian cancer. The aim of the group is to combine data from many studies, to provide a reliable assessment of the risks associated with these genes.

Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
The Consortium of Investigators of Modifiers of BRCA1/2 is a collaborative group of researchers working on genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers. The aim of CIMBA is to provide sufficient sample sizes to allow large scale studies in order to evaluate reliably the effects of genetic modifiers